Search Options Stock News and Analysis from Schaeffer's

2 Blue-Chip Drug Stocks in Focus Today After Earnings

https://www.schaeffersresearch.com/content/news/2025/02/04/2-blue-chip-drug-stocks-in-focus-today-after-earnings

2/4/2025 10:06 AM

Stocks are struggling for direction today, and one sector that represents this choppiness is blue-chip drugmakers. Merck & Co Inc (NYSE:MRK) and Pfizer Inc (NYSE:PFE) are both making outsized moves -...

Vaxcyte's Drug Update Pushes 2 Biotech Stocks Lower

https://www.schaeffersresearch.com/content/news/2024/09/03/vaxcytes-drug-update-pushes-2-biotech-stocks-lower

9/3/2024 2:10 PM

Vaxcyte Inc (NASDAQ:PCVX) stock is surging today, after the biotechnology company announced positive study results for its drug designed to prevent invasive pneumococcal disease in adults aged 50 or o...

Options Traders Blast 2 Pharma Socks After Earnings

https://www.schaeffersresearch.com/content/news/2024/07/30/options-traders-blast-2-pharma-socks-after-earnings

7/30/2024 10:12 AM

Pharmaceutical giants Merck & Co Inc (NYSE:MRK) and Pfizer Inc (NYSE:PFE) today reported second-quarter results. While the former beat top- and bottom-line estimates thanks in part to cancer drug K...

Merck Stock Edges Higher on FDA Vaccine Approval

https://www.schaeffersresearch.com/content/news/2024/06/18/merck-stock-edges-higher-on-fda-vaccine-approval

6/18/2024 10:04 AM

The U.S. Food and Drug Administration (FDA) approved Merck & Co Inc's (NYSE:MRK) next-generation vaccine to protect adults against the pneumococcal disease. The company said the vaccine could become...

Stocks Persevere Despite Week Rife With Volatility

https://www.schaeffersresearch.com/content/news/2024/04/26/stocks-persevere-despite-week-rife-with-volatility

4/26/2024 1:27 PM

The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) snapped six-day losing streaks to kick off the week, while the Dow Jones Industrial Average (DJI) saw a triple-digit win. The momentum kept up thr...

PEOPLE ALSO SEARCH FOR